Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-1991 | 03-1991 | 03-1990 | 12-1989 | 03-1989 | |
Cash Flows From Operating Activities | |||||
Net Income | N/A | -4,043 | -3,698 | -4,043 | -1,674 |
Depreciation Amortization | N/A | 753 | 607 | 753 | 201 |
Other Working Capital | N/A | 893 | 237 | 893 | -27 |
Other Operating Activity | 0 | 24 | 0 | 24 | 0 |
Operating Cash Flow | $N/A | $-2,372 | $-2,854 | $-2,372 | $-1,500 |
Cash Flows From Investing Activities | |||||
PPE Investments | N/A | -289 | -813 | -289 | -877 |
Other Investing Activity | 0 | 10 | 0 | 10 | 0 |
Investing Cash Flow | $N/A | $-278 | $-813 | $-278 | $-877 |
Cash Flows From Financing Activities | |||||
Other Financing Activity | 0 | 7,662 | -235 | 7,662 | 9,960 |
Financing Cash Flow | $N/A | $7,662 | $-235 | $7,662 | $9,960 |
Beginning Cash Position | N/A | 5,301 | 9,203 | 5,301 | 1,621 |
End Cash Position | N/A | 10,312 | 5,301 | 10,312 | 9,203 |
Net Cash Flow | $N/A | $5,011 | $-3,902 | $5,011 | $7,583 |
Free Cash Flow | |||||
Operating Cash Flow | N/A | -2,372 | -2,854 | -2,372 | -1,500 |
Free Cash Flow | 0 | -2,372 | -2,854 | -2,372 | -1,500 |